ALCHAR JACKSON: Open Payments
NPI 1932202876 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 18 payments from 9 companies in 2025. Trend: 2023 $536 · 2024 $384 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Amgen Inc. | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $32 |
| Novo Nordisk Inc | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Exact Sciences Corporation | 1 | $19 |
| Renalytix AI, Inc. | 1 | $17 |
Products named: FARXIGA, GVOKE HYPOPEN, EVENITY, MOUNJARO, AIRSUPRA, FREESTYLE LIBRE 3, LINZESS, Cologuard Collection Kit.
Industry payments across MS — which companies pay providers there.
